Allison Transmission Inc., the locally based maker of transmissions for trucks, buses and the military, set the interest rate it will pay on a $500 million term loan the company is seeking to refinance debt.
The number of homes that received an initial notice of default — the first step in the foreclosure process — increased 6 percent in July compared to the same month last year. Foreclosure starts rose 83 percent in Indiana.
The board of the largest U.S. shopping-mall owner wrongfully authorized a compensation package for CEO David Simon that included $120 million in special stock awards, a Louisiana pension fund claimed in the lawsuit filed Wednesday.
A combination of little rain and record heat has roasted corn crops, dried up ponds and streams and caused farmers to postpone purchases of everything from grain bins to smartphones.
Emmis Communications Corp. told a U.S. judge it will delay a scheduled Aug. 14 shareholder vote that could wipe out $34 million in unpaid preferred stockholder dividends until after she rules on a bid to block the balloting.
For-profit colleges put revenues above education, and charge students high tuition and loan rates that could leave them in debt for years, a Senate Democratic report said Monday. Stock in for-profit colleges tumbled after the report.
Livestock and poultry producers formally asked the Obama administration Monday to suspend the nation’s renewable fuels standard because it is causing “severe economic harm” as corn prices surged to a record.
The Obama administration Thursday announced a partnership with the industry in which WellPoint Inc., UnitedHealth Group Inc. and other insurers may try to share more billing data with the government to root out fraud.
WellPoint Inc.’s board, reacting to criticism after the health insurer cut its profit forecast on Wednesday, said the management team led by CEO Angela Braly has its full support.
Klepierre SA, the Paris-based shopping-center landlord that’s 27-percent owned by Simon Property Group Inc., said first-half profit was little changed as disposals curbed rental income growth.
WellPoint Inc. stock fell more than 12 percent Wednesday after the insurer’s quarterly earnings missed analyst estimates and it trimmed its full-year forecast.
Eli Lilly and Co. reported second-quarter profit that fell less than analysts had expected. The company raised its outlook for the rest of the year.
Bapineuzumab is in a race with a similar product from Indianapolis-based Eli Lilly and Co. to become the first therapy to target a cause for Alzheimer’s, rather than just its symptoms.
The NCAA on Monday morning slammed Penn State with an unprecedented series of penalties, including a $60 million fine and the loss of all coach Joe Paterno's victories from 1998-2011, in the wake of the Jerry Sandusky child sex abuse scandal.
Bill Johnson, the man who was CEO of Duke Energy Corp. for eight hours after its $17.8 billion takeover of Progress Energy Inc., began testifying Thursday to the North Carolina Utilities Commission.
WellPoint Inc. said it will pay for DNA testing for three children to see if they have an inherited heart disease their father suffers from that often strikes without warning, reversing an earlier decision to deny coverage.
Johnson & Johnson, Pfizer Inc. and Elan Corp are racing Indianapolis-based Eli Lilly and Co. to market the first broadly available drug designed to target a cause of Alzheimer’s, rather than just its symptoms. Analysts say the potential drugs are long shots.
The operator of Indiana Grand Casino and Indiana Downs horseracing track in Shelbyville has reached a $3.5 million settlement with the property’s former manager, The Cordish Co., that helps pave the way for its reorganization.
Duke Energy Corp. on Tuesday unexpectedly announced the resignation of Bill Johnson, previously named to be the CEO after its $17.8 billion takeover of Progress Energy Inc. James Rogers has been named CEO of the merged companies effective immediately.
Bristol-Myers Squibb Co. has agreed to pay $5.3 billion to acquire former Eli Lilly and Co. partner Amylin Pharmaceuticals Inc., a maker of diabetes therapies. The deal is valued at about $7 billion, which includes Amylin’s debt and a payment to Eli Lilly and Co. of about $1.7 billion.
